The agreement reserves Ro's right to terminate or suspend user access to the platform at any time, with or without cause or notice, subject to applicable law, while stating that the terms survive termination.
This analysis describes what Ro's agreement states, permits, or reserves. It does not constitute a legal determination about enforceability. Regulatory applicability and practical outcomes may vary by jurisdiction, enforcement context, and individual circumstances. Read our methodology
This provision establishes that access to Ro's telehealth platform, through which users manage ongoing medical treatment and prescription fulfillment, can be discontinued at Ro's discretion, which has operational significance for users in active care relationships.
Interpretive note: The practical application of a no-cause, no-notice termination right in a healthcare context may be constrained by state telehealth regulations and provider abandonment standards that are not addressed in the document.
Under this clause, Ro may terminate or suspend access to the platform for any reason and without advance notice, subject to applicable law; users in active treatment or prescription programs should be aware that platform access is not guaranteed to continue for any specific period.
Cross-platform context
See how other platforms handle Platform Access Termination and similar clauses.
Compare across platforms →Monitoring
Ro has changed this document before.
Receive same-day alerts, structured change summaries, and monitoring for up to 25 platforms.
"We reserve the right to terminate or suspend your access to the Services at any time, with or without cause, and with or without notice, subject to applicable law. If we terminate your access to the Services, these Terms will continue to apply.— Excerpt from Ro's Ro Terms of Use
(1) REGULATORY LANDSCAPE: Termination of access to a healthcare intermediary platform may intersect with state telehealth continuity of care obligations and healthcare provider abandonment standards that apply to the licensed providers facilitating care through the platform. The FTC's consumer protection authority applies to practices that may be unfair or deceptive in the context of healthcare service termination. (2) GOVERNANCE EXPOSURE: Medium. The 'without cause and without notice' standard is common in consumer platform terms but is more operationally significant in healthcare contexts where platform access is tied to ongoing prescription management and clinical care. The clause's survival provision means users remain bound by arbitration and other obligations post-termination. (3) JURISDICTION FLAGS: State telehealth regulations and healthcare provider abandonment standards may impose notice or continuity of care requirements that constrain how abruptly a telehealth platform can discontinue access for users in active treatment, depending on the jurisdiction and the nature of the care being provided. (4) CONTRACT AND VENDOR IMPLICATIONS: Institutional purchasers of Ro's services for employee health programs should evaluate whether the termination clause provides adequate protections for employees who rely on the platform for ongoing care, and whether service level agreements constrain Ro's termination rights. (5) COMPLIANCE CONSIDERATIONS: Legal teams should assess whether the termination-without-notice provision is reconciled with applicable state telehealth continuity of care requirements and whether Ro's operational practices include transition procedures for users in active clinical relationships at the time of termination.
Full compliance analysis
Regulatory citations, enforcement risk, and due diligence action items.
Free: track 3 platforms + weekly digest. Monitor: 25 platforms + same-day alerts. No credit card required.
Compliance Governance Intelligence
Need to monitor specific governance provisions?
Compliance includes provision-level monitoring, governance timelines, regulatory mapping, and audit-ready analysis.
Built from archived source documents, structured governance mappings, and historical version tracking.
This provision establishes that access to Ro's telehealth platform, through which users manage ongoing medical treatment and prescription fulfillment, can be discontinued at Ro's discretion, which has operational significance for users in active care relationships.
Under this clause, Ro may terminate or suspend access to the platform for any reason and without advance notice, subject to applicable law; users in active treatment or prescription programs should be aware that platform access is not guaranteed to continue for any specific period.
No. ConductAtlas is an independent monitoring service. We are not affiliated with, endorsed by, or sponsored by Ro.